SCHEMBL15977814

SCHEMBL15977814

c1ccc(-c2ccc(-c3ccc4c(-c5ccc6c(c5)C5(CCCC5)c5ccccc5-6)c5ccccc5c(-c5ccc6c(c5)C5(CCCC5)c5ccccc5-6)c4c3)nc2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.43
NPY5R Q15761 1/20 0.38
CNR2 P34972 1/20 0.38
PRMT5 O14744 2/20 0.36
WDR77 Q9BQA1 1/20 0.36
HSD11B1 P28845 2/20 0.35
NR1I2 O75469 1/20 0.35
PDE5A O76074 1/20 0.34
PDE1A P54750 1/20 0.34
PDE1B Q01064 1/20 0.34
PDE4D Q08499 1/20 0.34
PDE7A Q13946 1/20 0.34
PDE1C Q14123 1/20 0.34
PDE3A Q14432 1/20 0.34
P2RX7 Q99572 1/20 0.34
WNT3A P56704 2/20 0.33
AXL P30530 1/20 0.33
ABL1 P00519 1/20 0.32
CHEK2 O96017 1/20 0.32
DHODH Q02127 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977594 0.99 PDK2 (0.42) PDK2NPY5RCNR2PRMT5WDR77
SCHEMBL15977916 0.94 PDK2 (0.38) PDK2NPY5RCNR2HSD11B1NR1I2
SCHEMBL15977573 0.93 PDK2 (0.38) PDK2NPY5RCNR2HSD11B1NR1I2
SCHEMBL15977673 0.90 PDK2 (0.43) PDK2NPY5RCNR2PRMT5WDR77
SCHEMBL15977540 0.89 PDK2 (0.38) PDK2NPY5RALOX5AP
SCHEMBL15977735 0.88 PDK2 (0.43) PDK2NPY5RHSD11B1NR1I2PDE5A
SCHEMBL15977836 0.88 PDK2 (0.38) PDK2NPY5RPDE5APDE1APDE1B
SCHEMBL15977933 0.88 PDK2 (0.43) PDK2NPY5RPRMT5WDR77HSD11B1
SCHEMBL15977808 0.87 PDK2 (0.44) PDK2NPY5RPRMT5WDR77HSD11B1
SCHEMBL15977829 0.87 PDK2 (0.42) PDK2NPY5RPDE5APDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 PDK2 924/4885NPY5R 4572/4885CNR2 4512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.